
Aksia in exclusive talks to acquire MIR – report
Private equity firm Aksia is in exclusive talks to acquire Medical International Research (MIR), an Italian medical devices and software company specialising in spirometry devices, sources close to the deal told sister publication Mergermarket.
The publication reported that Aksia and MIR are due to sign a deal in the coming weeks, and that the deal involves the acquisition of 70% of the company.
De'Rossi & Associati is reportedly acting as a legal adviser to MIR, while Mediobanca is running the process.
The company is based in Rome and was founded in 1993 by two Italian entrepreneurs, Siro Brugnoli and Paolo Boschetti, who own a 50% stake each.
The company makes medical devices and develops software, and specialises in spirometry devices.
The group has a turnover of €15m and EBITDA of €4m, which, according to Mergermarket, could lead to a deal value of €30-40m.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater